Serum ALT and AST levels and their ratio (AST/ALT ratio) are commonly measured clinically as biomarkers for liver health (Dufour et al., 2000) and alcoholic liver disease (Andresen-Streichert et al., 2018). This evidence concerns the gene GPT and alcoholic liver diseases.